NIAGARA UNIVERSITY — Niagara University has been selected to receive a grant from the New York State Biodefense Commercialization Fund. The award of nearly $261,500 will be used to formulate a general anti-viral therapeutic using Cholestosome technology, a molecule delivery system developed at Niagara by Dr. Mary McCourt, professor of chemistry. It was one of […]